Penn Virginia Corporation (PVAC) Peer Comparison
$25.38
As on 17-Dec-2021EDT
Market cap
$647 Mln
Revenue (TTM)
$419 Mln
P/E Ratio
--
P/B Ratio
4.2
Div. Yield
0 %
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
647 | 1,402 | 255,541 | 12,177 | 3,244 |
Revenue ($ Mln) |
419 | 57,743 | 61,366 | 29,432 | 750 |
Net Profit ($ Mln) |
-128.66 | -8,956.01 | 10,446.00 | -621.00 | -64.19 |
Net Margin (%) |
-46.61 | -15.51 | 17.02 | -2.11 | -8.56 |
RoE (%) |
135.97 | -9.71 | 21.11 | -5.35 | -12.40 |
Price to Earnings |
-- | -- | 24.20 | 362.67 | -- |
Price-To-Book |
4.17 | 0.23 | 5.01 | 1.03 | 6.34 |
Income Statement ($ Mln)
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
419.23 | 70,680.23 | 26,617.00 | 25,285.00 | 178.00 |
|
Cost of Revenue
|
192.22 | 45,220.30 | 5,299.00 | 15,385.00 | 170.00 |
|
Gross Profit
|
56.46 | 25,459.93 | 21,318.00 | 9,900.00 | 178.00 |
|
Operating Expenses
|
26.90 | 19,001.77 | 16,156.00 | 5,320.00 | 306.00 |
|
Operating Profit (EBIT)
|
200.10 | 6,458.15 | 5,162.00 | 4,580.00 | -128.00 |
|
Other Income
|
-143.19 | 0.00 | -- | -- | -1,612.00 |
|
Profit before Tax
|
-105.67 | -4,930.94 | 3,916.00 | 3,119.00 | -116.00 |
|
Provision for Tax
|
-0.78 | 858.90 | 772.00 | 535.00 | -38.00 |
|
Profit after Tax (Net Income)
|
-128.66 | -1,250.34 | 3,196.00 | 2,422.00 | -78.00 |
|
Minority Interest
|
470.12 | 0.00 | -- | -- | 4,510.00 |
|
Consolidated Profit
|
-128.66 | -892.33 | -- | -- | -1,421.00 |
Liabilities ($ Mln)
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
173.19 | 87,939.03 | 15,622.00 | 16,253.00 | 291.00 |
|
Minority Interest
|
470.12 | 0.00 | -- | -- | 4,510.00 |
|
Non-Current Liabilities
|
769.81 | 139,597.63 | 30,784.00 | 28,114.00 | 1,107.00 |
|
Current Liabilities
|
222.92 | 43,709.67 | 20,307.00 | 8,296.00 | 173.00 |
|
Total Liabilities
|
907.33 | 271,246.33 | 66,729.00 | 52,663.00 | 1,571.00 |
Assets ($ Mln)
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,267.41 | 202,185.26 | 47,185.00 | 38,884.00 | 1,327.00 |
|
Current Assets
|
151.91 | 69,061.08 | 19,544.00 | 13,779.00 | 244.00 |
|
Total Assets
|
907.33 | 271,246.33 | 66,729.00 | 52,663.00 | 1,571.00 |
|
Total Debt*
|
748.93 | 133,304.59 | 20,380.00 | 21,622.00 | 16,745.00 |
|
Net Current Assets
|
-71.01 | 25,480.18 | -- | -- | 71.00 |
Cashflow ($ Mln)
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
221.78 | 33,160.92 | 4,799.00 | 2,294.00 | -55.00 |
|
Cash Flow from Investing Activities
|
-168.48 | -15,919.70 | -285.00 | 56.00 | -77.00 |
|
Cash from Financing Activities
|
-48.08 | -16,195.22 | -2,203.00 | -90.00 | 105.00 |
|
Net Cash Inflow / Outflow
|
5.22 | 0.00 | -- | -- | 1,568.00 |
Ratios
Profitability Ratios
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-32.57 | -0.55 | 9.49 | 6.72 | -0.47 |
|
ROE (%)
|
135.97 | -1.29 | 22.23 | 16.26 | -23.32 |
|
ROA (%)
|
-9.65 | -0.45 | 4.99 | 4.74 | -4.93 |
|
EBIT Margin (%)
|
-24.62 | -- | -- | -- | -- |
|
Net Margin (%)
|
-46.61 | -1.77 | 12.01 | 9.58 | 5.44 |
|
Cash Profit Margin (%)
|
0.00 | -- | -- | -- | -- |
Growth Ratios
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
26.93 | -0.31 | 0.09 | -0.06 | -0.63 |
|
EBIT Growth (%)
|
40.16 | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
25.08 | -127.03 | 139.40 | -26.78 | -1.30 |
|
EPS Growth (%)
|
-- | -1.28 | 1.39 | -0.27 | -0.01 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -3.67 | 20.54 | -- | -19.46 |
|
Price / Book Value
|
-- | 0.05 | 4.20 | -- | 5.22 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-4.03 | 4.06 | 9.65 | -- | -306.96 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
4.27 | 1.52 | 1.30 | 1.33 | 57.54 |
|
Short term debt to equity ratio
|
0.05 | 0.02 | 0.15 | 0.02 | 0.20 |
|
Current Ratio
|
0.68 | 1.58 | 0.96 | 1.66 | 1.41 |
|
Quick Ratio
|
0.65 | 1.54 | 0.76 | 1.45 | -- |
|
Interest Coverage
|
-3.02 | 0.53 | 4.08 | 4.05 | -4.92 |
Operating Efficiency Ratios
| Penn Virginia Corporation (PVAC) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.70 | 38.47 | 21.23 | 27.75 | 16.85 |
|
Asset Turnover
|
0.31 | 0.25 | 0.42 | 0.49 | 0.11 |
|
Receivable days
|
76.53 | 139.59 | 72.37 | 100.06 | 59.51 |
|
Inventory Days
|
5.77 | 11.28 | 248.73 | 54.25 | -- |
|
Payable days
|
31.30 | 227.48 | 142.13 | 45.63 | 124.61 |
|
Cash Conversion Cycle
|
51.00 | -76.61 | 178.96 | 108.68 | -- |